<code id='9D73C2E49C'></code><style id='9D73C2E49C'></style>
    • <acronym id='9D73C2E49C'></acronym>
      <center id='9D73C2E49C'><center id='9D73C2E49C'><tfoot id='9D73C2E49C'></tfoot></center><abbr id='9D73C2E49C'><dir id='9D73C2E49C'><tfoot id='9D73C2E49C'></tfoot><noframes id='9D73C2E49C'>

    • <optgroup id='9D73C2E49C'><strike id='9D73C2E49C'><sup id='9D73C2E49C'></sup></strike><code id='9D73C2E49C'></code></optgroup>
        1. <b id='9D73C2E49C'><label id='9D73C2E49C'><select id='9D73C2E49C'><dt id='9D73C2E49C'><span id='9D73C2E49C'></span></dt></select></label></b><u id='9D73C2E49C'></u>
          <i id='9D73C2E49C'><strike id='9D73C2E49C'><tt id='9D73C2E49C'><pre id='9D73C2E49C'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:8
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more
          Despite FDA approval for Lyfgenia, Bluebird faces stiff competition
          Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

          ChristineKao/STATTheFoodandDrugAdministration’sapprovalonFridayoftwogenetherapiesforsicklecelldiseas

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Roche to buy Carmot Therapeutics, developer of obesity drugs

          SebastienBozon/AFPviaGettyImagesLONDON—Theboomingobesitymarketisattractinganotherplayer,aspharmagian